Hawkins (HWKN) Expected to Announce Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) is projected to announce its Q1 2027 results after the market closes on Wednesday, July 29th. Analysts expect Hawkins to post earnings of $1.41 per share and revenue of $313.4220 million for the quarter. Individuals may review the information on the company’s upcoming Q1 2027 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 4:10 PM ET.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Hawkins had a return on equity of 16.08% and a net margin of 7.53%.The firm had revenue of $265.91 million during the quarter, compared to analysts’ expectations of $255.28 million. On average, analysts expect Hawkins to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Hawkins Price Performance

Shares of NASDAQ:HWKN opened at $139.03 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.21 and a quick ratio of 1.46. Hawkins has a 1-year low of $117.98 and a 1-year high of $186.15. The company has a market capitalization of $2.91 billion, a P/E ratio of 35.56, a P/E/G ratio of 2.51 and a beta of 0.78. The firm’s 50 day simple moving average is $150.33 and its two-hundred day simple moving average is $150.50.

Hawkins Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were paid a $0.19 dividend. The ex-dividend date of this dividend was Friday, May 29th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.5%. Hawkins’s dividend payout ratio is 19.44%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, July 14th. Barclays set a $170.00 target price on shares of Hawkins and gave the stock an “equal weight” rating in a report on Tuesday, June 30th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $185.00.

Institutional Investors Weigh In On Hawkins

A number of institutional investors have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC purchased a new position in shares of Hawkins in the fourth quarter worth $29,000. Simplex Trading LLC grew its stake in Hawkins by 246.0% during the fourth quarter. Simplex Trading LLC now owns 346 shares of the specialty chemicals company’s stock valued at $49,000 after acquiring an additional 246 shares in the last quarter. Advisory Services Network LLC purchased a new position in Hawkins during the third quarter valued at $79,000. iSAM Funds UK Ltd bought a new stake in Hawkins in the 3rd quarter valued at $102,000. Finally, Evergreen Capital Management LLC bought a new stake in Hawkins in the 2nd quarter valued at $208,000. 69.71% of the stock is owned by hedge funds and other institutional investors.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.